SANA
Sana Biotechnology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.85
−1.79%Aug 9, 2026, 13:35 UTC
Sana Biotechnology Inc. is scheduled to report its second-quarter results on Monday, with analysts expecting a loss of 15 cents per share and no revenue.
Source: